Merck Kgaa
(MRK.D.DX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1999 | 12-1998 | 12-1997 | 12-1996 | 12-1995 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 1,144,800 | 1,015,100 | 1,034,300 | 927,100 | 859,200 |
| Accounts receivable | -752,900 | -579,100 | -271,700 | -224,700 | -244,100 |
| Other Working Capital | -3,454,400 | -741,700 | 17,000 | 64,900 | -423,600 |
| Other Operating Activity | 9,193,200 | 5,634,000 | 5,537,000 | 4,660,400 | 2,752,700 |
| Operating Cash Flow | $6,130,700 | $5,328,300 | $6,316,600 | $5,427,700 | $2,944,200 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,560,500 | 612,800 | -538,800 | -1,196,700 | 315,600 |
| Purchase Of Investment | -42,211,200 | -29,675,400 | -22,986,700 | -15,719,100 | -13,772,300 |
| Sale Of Investment | 40,308,700 | 28,618,900 | 22,075,400 | 15,079,200 | 12,430,100 |
| Other Investing Activity | 1,646,000 | 432,300 | -152,600 | -142,700 | -295,700 |
| Investing Cash Flow | $-2,817,000 | $-11,400 | $-1,602,700 | $-1,979,300 | $-1,322,300 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 322,900 | 490,100 | 413,300 | 442,200 | 1,283,600 |
| Common Stock Repurchased | -3,582,100 | -3,625,500 | -3,572,800 | -2,493,300 | -1,570,900 |
| Dividend Paid | -2,589,700 | -2,253,100 | -2,039,900 | -1,728,900 | -1,539,800 |
| Other Financing Activity | 1,979,500 | 1,467,600 | 340,500 | -57,300 | 425,700 |
| Financing Cash Flow | $-3,869,400 | $-3,920,900 | $-4,858,900 | $-3,837,300 | $-1,401,400 |
| Exchange Rate Effect | -28,600 | 85,100 | -82,300 | -106,100 | 22,900 |
| Beginning Cash Position | 2,606,200 | 1,125,100 | 1,352,400 | 1,847,400 | 1,604,000 |
| End Cash Position | 2,021,900 | 2,606,200 | 1,125,100 | 1,352,400 | 1,847,400 |
| Net Cash Flow | $-555,700 | $1,396,000 | $-145,000 | $-388,900 | $220,500 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,130,700 | 5,328,300 | 6,316,600 | 5,427,700 | 2,944,200 |
| Capital Expenditure | -2,560,500 | -1,973,400 | -1,448,800 | -1,196,700 | -1,005,500 |
| Free Cash Flow | 3,570,200 | 3,354,900 | 4,867,800 | 4,231,000 | 1,938,700 |